← Evidence map

ArticleGut and liver2018

Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety.

Hye Won Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2018
2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29409309